Quarterly report [Sections 13 or 15(d)]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.25.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2025
Accounting Policies [Abstract]  
SCHEDULE OF RECLASSIFIED PRIOR YEAR EXPENSES MEASUREMENTS

  

Account                        
    Three Months Ended September 30, 2024     Nine Months Ended September 30, 2024  
Account   Previously
Recorded
Balance
    Corrected
Balance
    Reclassification
Made
    Previously
Recorded
Balance
    Corrected
Balance
    Reclassification
Made
 
Statement of Operations                                                
Revenue     14,006,349       13,366,134       (640,215 )     41,816,348       40,305,032       (1,511,316 )
Cost of goods sold     8,131,015       7,490,800       (640,215 )     24,563,628       23,052,312       (1,511,316 )
Gross profit     6,386,407       6,386,407       -       19,104,536       19,104,536       -  
SCHEDULE OF FAIR VALUE MEASUREMENTS

The following table summarizes the financial instruments of the Company at fair value based on the valuation approach applied to each class of security as of September 30, 2024:

  

                 
          Fair Value Measurement at Reporting Date Using  
   

Carrying

Value at

September 30, 2024

   

Quoted

Prices

in Active

Markets for

Identical

Assets

(Level 1)

   

Significant

Other

Observable

Inputs

(Level 2)

   

Significant

Unobservable

Inputs

(Level 3)

 
Liabilities:                                
Fair Value of potential Share Adjustment   $ 35,547,015     $ -     $ -     $ 35,547,015  
Total Liabilities   $ 35,547,015     $ -     $ -     $ 35,547,015  
SCHEDULE OF FAIR VALUE OF SHARE ADJUSTMENT

The following table presents a reconciliation of the opening and closing balances of the Fair Value of Share Adjustment for the nine months ended September 30, 2025:

  

    Fair Value of
Share Adjustment
 
       
Balance at December 31, 2024   $ 9,299,703  
Fair Value of Shares Issued     (5,607,174 )
Gain on Fair Value of Share Adjustment     (3,692,529 )
Balance at September 30, 2025   $ -  
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF NET LOSS PER SHARE

The following table summarizes the securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive due to the Company’s net income (loss) position even though the exercise price could be less than the average market price of the Class A common stock:

  

         
    Nine Months Ended September 30,  
    2025     2024  
Warrants     38,341,664       39,350,000  
Stock options     5,540,000       4,760,000  
Acquisition Stock Consideration Payable     -       366,464,075  
Total     43,881,664       410,574,075